Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01356862
What this trial is testing

Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer

Who this might be right for
Breast Cancer
Alliance Pour La Recherche en Cancerologie 91
Testing effectiveness (Phase 2)Study completedNCT00463788
What this trial is testing

Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer

Who this might be right for
Breast Neoplasm
Merck KGaA, Darmstadt, Germany 181
Early research (Phase 1)Study completedNCT00001270
What this trial is testing

Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma

Who this might be right for
Breast NeoplasmsLymphomaNeoplasm Metastasis+1 more
National Cancer Institute (NCI) 85
Not applicableUnknownNCT04489992
What this trial is testing

Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System

Who this might be right for
AI (Artificial Intelligence)Mammary CancerLung Cancer+6 more
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department 133,000
Not applicableEnded earlyNCT02581709
What this trial is testing

An Intervention Programme to Reduce Cognitive Impairment Due to Cancer

Who this might be right for
Breast NeoplasmsColorectal Neoplasms
Queen's University, Belfast 15
Not applicableNot Yet RecruitingNCT07649902
What this trial is testing

Artificial Intelligence Powered Digital Education Based on the Neuman Systems Model for Breast Cancer Patients Receiving Radiotherap

Who this might be right for
Breast CancerRadiodermatitis
Ataturk University 38
Testing effectiveness (Phase 2)Study completedNCT00001239
What this trial is testing

Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
National Cancer Institute (NCI) 100
Not applicableStudy completedNCT05184257
What this trial is testing

Zoladex® 10.8 BC RWS

Who this might be right for
Breast Cancer
AstraZeneca 1,176
Large-scale testing (Phase 3)Study completedNCT00459771
What this trial is testing

Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 210
Not applicableLooking for participantsNCT07423039
What this trial is testing

Auricular Acupressure for Perioperative Anxiety and Pain in Therapeutic Breast Surgery (ROSA)

Who this might be right for
Breast Cancer Females
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) 66
Early research (Phase 1)Study completedNCT03242239
What this trial is testing

A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects

Who this might be right for
Healthy
Alteogen, Inc. 105
Not applicableUnknownNCT01336257
What this trial is testing

Effectiveness of a Decision Support System in Improving the Diagnosis and Screening Rate of Breast Cancer

Who this might be right for
Breast Cancer
Hospital Italiano de Buenos Aires 2,200
Testing effectiveness (Phase 2)Study completedNCT01730612
What this trial is testing

ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA

Who this might be right for
HER2 Negative Breast Carcinoma Expressing CEA
Nantes University Hospital 23
Not applicableStudy completedNCT03214419
What this trial is testing

Study First Step to Virtual Breast Cancer Localization

Who this might be right for
Breast Cancer
University Hospital, Montpellier 10
Not applicableStudy completedNCT05022511
What this trial is testing

Three Birds With One Stone

Who this might be right for
Uterine Cervical CancerUterine Cervix CancerUterine Cervical Neoplasm+5 more
University of Aarhus 27,099
Not applicableActive Not RecruitingNCT06522971
What this trial is testing

Effects of Physical Exercise on Response to Treatement in Breast Cancer

Who this might be right for
Breast Cancer
Latvian Biomedical Research and Study Centre 55
Testing effectiveness (Phase 2)Study completedNCT02876302
What this trial is testing

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer (IBC)
Dana-Farber Cancer Institute 23
Very early researchWithdrawnNCT01302002
What this trial is testing

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Who this might be right for
Breast Cancer
Instituto Nacional de Cancer, Brazil
Not applicableEnded earlyNCT01187381
What this trial is testing

An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 250
Testing effectiveness (Phase 2)UnknownNCT05134519
What this trial is testing

RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Xijing Hospital 20
Next Page